Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Tuberculosis

  Free Subscription


23.12.2018

1 Eur Respir J
1 Infect Immun
1 J Immunol
2 Lancet Glob Health
4 Lancet Infect Dis
4 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Eur Respir J

  1. CHIANG CY, Trebucq A, Piubello A, Rieder HL, et al
    Should gatifloxacin be included in the model list of essential medicines?
    Eur Respir J. 2018;51.
    PubMed     Text format    


    Infect Immun

  2. GOPALAKRISHNAN A, Dietzold J, Verma S, Bhagavathula M, et al
    Toll-like receptor 2 prevents neutrophil-driven immunopathology during infection with Mycobacterium tuberculosis by curtailing CXCL5 production.
    Infect Immun. 2018 Dec 17. pii: IAI.00760-18. doi: 10.1128/IAI.00760.
    PubMed     Text format     Abstract available


    J Immunol

  3. AERTS L, Selis E, Corbiere V, Smits K, et al
    HBHA-Induced Polycytotoxic CD4(+) T Lymphocytes Are Associated with the Control of Mycobacterium tuberculosis Infection in Humans.
    J Immunol. 2018 Dec 17. pii: jimmunol.1800840. doi: 10.4049/jimmunol.1800840.
    PubMed     Text format     Abstract available


    Lancet Glob Health

  4. CORMIER M, Schwartzman K, N'Diaye DS, Boone CE, et al
    Proximate determinants of tuberculosis in Indigenous peoples worldwide: a systematic review.
    Lancet Glob Health. 2019;7:e68-e80.
    PubMed     Text format     Abstract available

  5. BASTA PC, de Sousa Viana PV
    Determinants of tuberculosis in Indigenous people worldwide.
    Lancet Glob Health. 2019;7:e6-e7.
    PubMed     Text format    


    Lancet Infect Dis

  6. CUDAHY PGT, Andrews JR, Bilinski A, Dowdy DW, et al
    Spatially targeted screening to reduce tuberculosis transmission in high-incidence settings.
    Lancet Infect Dis. 2018 Dec 13. pii: S1473-3099(18)30443.
    PubMed     Text format     Abstract available

  7. SEKKIDES O
    Understanding tuberculosis transmission might be the gamechanger we need.
    Lancet Infect Dis. 2018 Dec 13. pii: S1473-3099(18)30741.
    PubMed     Text format    

  8. PETERS JS, Andrews JR, Hatherill M, Hermans S, et al
    Advances in the understanding of Mycobacterium tuberculosis transmission in HIV-endemic settings.
    Lancet Infect Dis. 2018 Dec 13. pii: S1473-3099(18)30477.
    PubMed     Text format     Abstract available

  9. KHAN PY, Yates TA, Osman M, Warren RM, et al
    Transmission of drug-resistant tuberculosis in HIV-endemic settings.
    Lancet Infect Dis. 2018 Dec 13. pii: S1473-3099(18)30537.
    PubMed     Text format     Abstract available


    PLoS One


  10. Correction: Molecular modelling and simulation studies of the Mycobacterium tuberculosis multidrug efflux pump protein Rv1258c.
    PLoS One. 2018;13:e0209717.
    PubMed     Text format     Abstract available

  11. KIRIRABWA NS, Kimuli D, DeJene S, Nanziri C, et al
    Response to anti-tuberculosis treatment by people over age 60 in Kampala, Uganda.
    PLoS One. 2018;13:e0208390.
    PubMed     Text format     Abstract available

  12. VO LNQ, Vu TN, Nguyen HT, Truong TT, et al
    Optimizing community screening for tuberculosis: Spatial analysis of localized case finding from door-to-door screening for TB in an urban district of Ho Chi Minh City, Viet Nam.
    PLoS One. 2018;13:e0209290.
    PubMed     Text format     Abstract available

  13. READHEAD A, Chang AH, Ghosh JK, Sorvillo F, et al
    Challenges and solutions to estimating tuberculosis disease incidence by country of birth in Los Angeles County.
    PLoS One. 2018;13:e0209051.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: